TNF and psoriasis: Additionally, anti-tumor necrosis factor (anti-TNF) agents and other immunosuppressive medications, like methotrexate and cyclosporine, occasionally employed in psoriasis management, may also heighten the risk of pulmonary infections, including SARS-CoV-2 [9].